Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5879 posts found.

Government unveils £20bn plan to revitalise NHS in England

January 8, 2019 Manufacturing and Production NHS funding, NHS< funding, brexit, government, health, policy

Theresa May and the chief executive of NHS England, Simon Stevens, have announced a new ten year plan for the …
News
takeda_global_hq

Takeda completes Shire acquisition

January 8, 2019 Manufacturing and Production M&A, MA, Shire, Takeda, acquisition, deal, pharma

Japanese firm Takeda Pharmaceuticals has successfully completed its acquisition of Shire Plc. The long anticipated deal has propelled the firm …
News
abbvie_0

AbbVie records an estimated $4billion in impairment charges after failure of cancer drug Rova-T

January 8, 2019 Manufacturing and Production AbbVie, M&A, MA, Stemcentrx, acquisition, rova-t

US firm AbbVie has said that it will record an estimated $4 billion in impairment charges related to the abandonment …
News
jallal

Immunocore names AstraZeneca exec as new CEO

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical stage biotechnology company Immunocore has announced the appointment of AstraZeneca executive Bahija Jallal as the company’s new CEO. The …
Appointment
mark_mallon

Ironwood Pharmaceuticals names AstraZeneca veteran Mark Mallon as new CEO

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, CEO, Ironwood, Sweden, mark mallon

The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation for the …
Appointment
lilly_building_with_american_flag_web

Eli Lilly to buy Loxo Oncology in deal worth $8 billion

January 7, 2019 Manufacturing and Production Cancer, Eli Lilly, Loxo Oncology, gene therapy, personalised medicine

US firm Eli Lilly & Co today announced a definitive agreement for the acquisition of Connecticut-based company Loxo Oncology in …
News

How tech is powering precision treatment

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Precision Medicine, pharma, tech

As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …
Feature
img_4190-e1376666350337-web

MHRA issues recall of irbesartan blood pressure meds over carcinogen contamination concerns

January 4, 2019 Manufacturing and Production, Medical Communications MHRA, irbesartan, pharma, sartan, valsartan

Following a number of recalls issued in the US and Europe in the latter half of 2018 for the blood …
News
38707779504_4778627b30_z

Top Ten most popular articles on Pharmafile.com of 2018!

December 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Business, biosimilars, brexit, pharma, top 10

Brexit, business and biosimilars, seemed to be the three themes of 2018. As Brexit negotiations reached a stalemate the pharmaceutical …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Eli Lilly, Novartis, Teva, Tilray, brexit, celltrion, pharma, top 10

Deals dominated this week as GSK and Pfizer announced that they would combine their consumer healthcare units in a collaboration …
News
liz_barrett

Novartis Oncology CEO steps down after 11 months

December 20, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Liz Barret, the CEO of Swiss firm Novartis Oncology has said that she is standing down after being in the …
Appointment
82958bfc7df1311fd17a008495fc-1456375

Pharma in 2018: Looking back, looking forward

December 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, Alligator Bioscience, Eisai, Gilead, Mundipharma, pharma

2018 has been a year characterised by uncertainty, but also significant leaps in research, access, and industry deals. With 2019 …
Feature

NHS spends £26 million on consultancy

December 18, 2018 Manufacturing and Production BMA, Consultancy, Jobs, NHS, health

Private consultancy firms were paid at least £26 million as part of a reorganisation of the NHS, in what has …
News

Celltrion and Teva’s Herceptin biosimilar secures FDA approval in breast cancer

December 18, 2018 Manufacturing and Production, Sales and Marketing Herceptin, Herzuma, Teva, celltrion, pharma

Israeli and South Korean-based drug makers Teva and Celltrion are set to move in on the market share occupied by …
News

Eli Lilly’s Taltz shows superiority over AbbVie’s Humira

December 18, 2018 Manufacturing and Production Eli Lilly, Humira, Taltz, arthritis, immune system

A study has found that Eli Lilly’s Taltz (ixekizumab) met the primary, and all secondary endpoints, in patients with active …
News
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026